• Citer

Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: A systematic review and pooled analysis

par Zagouri, Flora;Sergentanis, Theodoros Nikolaos Ikolaos T.N.;Dimopoulos, Meletios;Bartsch, Rupert;Berghoff, Anna Sophie;Preusser, Matthias;de Azambuja, Evandro ;Chrysikos, Dimosthenis
Référence Breast cancer research and treatment, 139, 1, page (13-22)
Publication Publié, 2013-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: A systematic review and pooled analysis
Auteur:	Zagouri, Flora; Sergentanis, Theodoros Nikolaos Ikolaos T.N.; Dimopoulos, Meletios; Bartsch, Rupert; Berghoff, Anna Sophie; Preusser, Matthias; de Azambuja, Evandro; Chrysikos, Dimosthenis
Informations sur la publication:	Breast cancer research and treatment, 139, 1, page (13-22)
Statut de publication:	Publié, 2013-05
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	HER2-positive
	Intrathecal
	Meningeal carcinomatosis
	Trastuzumab
MeSH keywords:	Antibodies, Monoclonal, Humanized -- administration & dosage
	Antineoplastic Agents -- administration & dosage
	Breast Neoplasms -- drug therapy -- genetics -- pathology
	Disease-Free Survival
	Female
	Genes, erbB-2
	Humans
	Injections, Spinal
	Meningeal Carcinomatosis -- drug therapy -- genetics -- secondary
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-013-2525-y
	info:scp/84877580501
	info:pmid/23588955